Clinical Trial

Cancer Survivors' Fear of Cancer Recurrence

Study acronym: MHPII
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to develop and evaluate the tailored support for the fear of cancer recurrence in breast, head and neck, colon-rectal or prostate cancer survivors. Based on screening for fear of cancer recurrence, different levels of supportive care will be provided, starting with the oncology nurses' health education and information for those having a lower level of concern. Those who have medium or higher levels of concerns will be randomized to receive "stepping up" either a "ConquerFear psychological cognitive training" or a "healthy lifestyle - individualized exercise and nutrition guidance".
Trial Details
NCT Number NCT07542821
Lead Sponsor National Taipei University of Nursing and Health Sciences
Collaborators: Ministry of Health and Welfare, Taiwan, Koo Foundation Sun Yat-Sen Cancer Center
Conditions Fear of Cacer Recurrence in Cancer Survivorws
Enrollment 150 participants
Start Date 2026-04-15
Primary Completion 2028-05-31 (estimated)
Study Completion 2028-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-21